# Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD

> **NCT04759105** · PHASE2 · COMPLETED · sponsor: **Fondazione Policlinico Universitario Campus Bio-Medico** · enrollment: 48 (actual)

## Conditions studied

- Intervertebral Disc Degeneration
- Chronic Low-back Pain

## Interventions

- **DRUG:** Autologous BM-MSC
- **OTHER:** Sham Procedure

## Key facts

- **NCT ID:** NCT04759105
- **Lead sponsor:** Fondazione Policlinico Universitario Campus Bio-Medico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-03
- **Primary completion:** 2023-11-27
- **Final completion:** 2023-11-27
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-05-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04759105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04759105, "Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04759105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*